About this trial
This study aims to compare the clinical outcomes of bilateral alveolar cleft reconstruction using double iliac corticocancellous bone block grafts versus conventional autogenous particulate bone grafting. The study will evaluate graft stability, bone volume, and postoperative complications in patients with bilateral alveolar clefts. Participants will be allocated into two groups, each receiving one of the two grafting techniques. Clinical and radiographic assessments will be performed during follow-up to determine the effectiveness and predictability of each method
Eligibility criteria
Qualifiers
patients diagnosed with bilateral alveolar cleft requiring secondary alveolar bone graft.
Medically fit for surgery under general anesthesia.
Adequate soft tissue coverage at the cleft site.
Patients (or guardians) able to provide informed consent.
Disqualifiers
Unilateral alveolar cleft.
Presence of systemic diseases affecting bone healing (e.g., Diabetes Mellitus uncontrolled, osteoporosis).
Syndromic cleft patients.
Poor oral hygiene or active infection at the surgical site.
Trial design
Treatments tested in this trial
- Iliac Corticocancellous Bone Block Graft
- Autogenous Particulate Bone Graft